These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26095700)

  • 1. Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
    Shin SK; Kim JH; Park H; Kwon OS; Lee HJ; Yeon JE; Byun KS; Suh SJ; Yim HJ; Kim YS; Kim JH
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1775-81. PubMed ID: 26095700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
    Shim JH; Lee HC; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
    J Hepatol; 2010 Feb; 52(2):176-82. PubMed ID: 20006394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.
    Xu Y; Zhang YG; Wang X; Qi WQ; Qin SY; Liu ZH; Jiao J; Wang JB
    World J Gastroenterol; 2015 Jul; 21(25):7869-76. PubMed ID: 26167087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus.
    Huang LH; Qiu YW; Hua HY; Niu XH; Wu PF; Wu HY; Zhu HY; Yang XJ; Yao SZ; Li YG
    Int J Infect Dis; 2013 Aug; 17(8):e606-9. PubMed ID: 23490092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
    Hyun JJ; Seo YS; Yoon E; Kim TH; Kim DJ; Kang HS; Jung ES; Kim JH; An H; Kim JH; Yim HJ; Yeon JE; Lee HS; Byun KS; Um SH; Kim CD; Ryu HS
    Liver Int; 2012 Apr; 32(4):656-64. PubMed ID: 22099071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better?
    Koksal AR; Alkim H; Boga S; Ergun M; Bayram M; Ozguven BY; Alkim C
    Am J Ther; 2016; 23(2):e429-38. PubMed ID: 25650531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.
    Tsai MC; Yu HC; Hung CH; Lee CM; Chiu KW; Lin MT; Tseng PL; Chang KC; Yen YH; Chen CH; Hu TH
    J Gastroenterol Hepatol; 2014 Mar; 29(3):568-75. PubMed ID: 24716215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.
    Peng J; Cai S; Yu T; Chen Y; Zhu Y; Sun J
    Scand J Clin Lab Invest; 2016; 76(2):133-42. PubMed ID: 26878877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluation.
    Yeh CS; Hsu CW; Liang KH; Chen YC; Lin CL; Chien RN; Hu TH; Lin WR; Lai MW; Chu YD; Yeh CT
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1530-1537. PubMed ID: 29424069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of FibroScan, APRI, and FIB-4 in chronic hepatitis B patients with significant liver histological changes receiving 3-year entecavir therapy.
    Li Q; Chen L; Zhou Y
    Clin Exp Med; 2018 May; 18(2):273-282. PubMed ID: 29350286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
    Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
    Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
    Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
    J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum albumin and prothrombin time before entecavir treatment in chronic hepatitis B or cirrhosis are related to amelioration of liver function after treatment.
    Saito M; Seo Y; Yano Y; Momose K; Hirano H; Yoshida M; Azuma T
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1369-76. PubMed ID: 23974961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.